Antifungal activity of the echinocandin anidulafungin (VER002, LY-303366) against yeast pathogens: A comparative study with M27-A microdilution method

Journal of Antimicrobial Chemotherapy

Volumn 51, Issue 1, 2003, Pages 163-166

  Arévalo, María Pilar ^a   Carrillo Muñoz, Alfonso Javier ^b   Salgado, Javier ^a,c   Cardenes, Delia ^a   Brió, Sonia ^b   Quindós, Guillermo ^d   Espinel Ingroff, Ana ^e  

^a UNIVERSIDAD DE LA LAGUNA   (Spain)

^b Associacio Catalana d'Intelligencia Artificial   (Spain)

^c HOSPITAL UNIVERSITARIO NUESTRA SEÑORA DE CANDELARIA   (Spain)

^d UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^e VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIDULAFUNGIN; CILOFUNGIN; FLUCONAZOLE; ITRACONAZOLE;

ANALYTIC METHOD; ANTIBIOTIC SENSITIVITY; ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CONTROLLED STUDY; DILUTION; FUNGUS ISOLATION; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; YEAST;

ANTIBIOTICS, ANTIFUNGAL; CANDIDA; HUMANS; MICROBIAL SENSITIVITY TESTS; PEPTIDES, CYCLIC;

EID: 12244253742     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkg018     Document Type: Article

References (10)

1. Sandven, P. (2000). Epidemiology of candidemia. Revista Iberoamericana de Micologia 17, 73-81.
2. Denning, D. W. (1997). Echinocandins and pneumocandins, a new antifungal class with a novel mode of action. Journal of Antimicrobial Chemotherapy 40, 611-4.
3. National Committee for Clinical Laboratory Standards. (1997). Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeast: Approved Standard M27-A. NCCLS, Wayne, PA, USA.
4. Conly, J., Rennie, R., Johnson, J., Farah, S. & Hellman, L. (1992). Disseminated candidiasis due to amphotericin B-resistant Candida albicans. Journal of Infectious Diseases 165, 761-4.
5. Oakley, K. L., Moore, C. B. & Denning, D. W. (1998). In vitro activity of the echinocandin antifungal agent LY 303366 in comparison with itraconazole and amphotericin B against Aspergillus spp. Antimicrobial Agents and Chemotherapy 42, 2726-30.
6. Powderly, W. G., Kobayashi, G. S., Herzig, G. P. & Medoff, G. (1988). Amphotericin B-resistant yeast infection in severely immunocompromised patients. American Journal of Medicine 84, 826-32.
7. Espinel-Ingroff, A. (1998). Comparison of in vitro activities of the new triazole SCH56592 and the echinocandin MK-0991 (L-743,872) and LY303366 against opportunistic filamentous and dimorphic fungi and yeasts. Journal of Clinical Microbiology 36, 2950-6.
8. Karlowsky, J. A., Harding, G. A., Zelnitsky, S. A., Hoban, D. J., Kabani, A., Bello, T. Y. et al. (1997). In vitro kill curves of a new semisynthetic echinocandin, LY 303366, against fluconazole sensitive and resistant Candida species. Antimicrobial Agents and Chemotherapy 41, 2576-8.
9. Zhanel, G. G., Karlowsky, J. A., Harding, G. A., Valko, T. V., Zelenitsky, S. A., Friesen, M. et al. (1997). In vitro activity of a new echinocandin, LY-303366, against systemic isolates of Candida species, Cryptococcus neoformans, Blastomyces dermatitidis, and Aspergillus species. Antimicrobial Agents and Chemotherapy 41, 863-5.
10. Chavez, M., Bernal, S., Valverde, A., Gutierrez, M. J., Quindós, G. & Martin-Mazuelos, E. (1999). In-vitro activity of voriconazole (UK-109,496), LY303366 and other antifungal agents against oral Candida spp. isolates from HIV-infected patients. Journal of Antimicrobial Chemotherapy 44, 697-700.